Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Non-Invasive Brain Trauma Monitoring Devices Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Non-Invasive Brain Trauma Monitoring Devices Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Non-Invasive Brain Trauma Monitoring Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Non-Invasive Brain Trauma Monitoring Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Monitoring Devices
4.3.1. Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Intra Cranial Pressure Monitor
4.3.2.1. Intra Cranial Pressure Monitor Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. MRI Scanner
4.3.3.1. MRI Scanner Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. CT Scanner
4.3.4.1. CT Scanner Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. PET Scanner
4.3.5.1. PET Scanner Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.6. EEG
4.3.6.1. EEG Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.7. MEG
4.3.7.1. MEG Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.8. Others
4.3.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Consumables
4.4.1. Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Electrodes
4.4.2.1. Electrodes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Sensors
4.4.3.1. Sensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Fibre Optic Cables
4.4.4.1. Fibre Optic Cables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Others
4.4.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Non-Invasive Brain Trauma Monitoring Devices Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Non-Invasive Brain Trauma Monitoring Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
5.3. Hospitals
5.3.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Neurological Centers
5.4.1. Neurological Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Non-Invasive Brain Trauma Monitoring Devices Market: Regional Estimates & Trend Analysis
6.1. Non-Invasive Brain Trauma Monitoring Devices Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North America Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East & Africa (MEA)
6.6.1. MEA Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Advanced Brain Monitoring, Inc.
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/Strategic Initiatives
7.4.2. Cadwell Industries, Inc.
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/Strategic Initiatives
7.4.3. Canon Medical Systems Corporations
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/Strategic Initiatives
7.4.4. Compumedics Ltd.
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/Strategic Initiatives
7.4.5. Magstim EGI
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/Strategic Initiatives
7.4.6. General Electric Company
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/Strategic Initiatives
7.4.7. Hitachi, Ltd.
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/Strategic Initiatives
7.4.8. Koninklijke Philips N.V.
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/Strategic Initiatives
7.4.9. Medtronic
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/Strategic Initiatives
7.4.10. Natus Medical Incorporated
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/Strategic Initiatives
7.4.11. NeuroLogica Corp.
7.4.11.1. Participant’s Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Recent Developments/Strategic Initiatives
7.4.12. NeuroWave Systems, Inc.
7.4.12.1. Participant’s Overview
7.4.12.2. Financial Performance
7.4.12.3. Product Benchmarking
7.4.12.4. Recent Developments/Strategic Initiatives
7.4.13. Nihon Kohden Corporation
7.4.13.1. Participant’s Overview
7.4.13.2. Financial Performance
7.4.13.3. Product Benchmarking
7.4.13.4. Recent Developments/Strategic Initiatives
7.4.14. Noraxon USA
7.4.14.1. Participant’s Overview
7.4.14.2. Financial Performance
7.4.14.3. Product Benchmarking
7.4.14.4. Recent Developments/Strategic Initiatives
7.4.15. RAUMEDIC AG
7.4.15.1. Participant’s Overview
7.4.15.2. Financial Performance
7.4.15.3. Product Benchmarking
7.4.15.4. Recent Developments/Strategic Initiatives
7.4.16. Sense Neuro
7.4.16.1. Participant’s Overview
7.4.16.2. Financial Performance
7.4.16.3. Product Benchmarking
7.4.16.4. Recent Developments/Strategic Initiatives
7.4.17. Siemens
7.4.17.1. Participant’s Overview
7.4.17.2. Financial Performance
7.4.17.3. Product Benchmarking
7.4.17.4. Recent Developments/Strategic Initiatives
7.4.18. Sophysa
7.4.18.1. Participant’s Overview
7.4.18.2. Financial Performance
7.4.18.3. Product Benchmarking
7.4.18.4. Recent Developments/Strategic Initiatives
7.4.19. Spiegelberg GmbH & Co. KG
7.4.19.1. Participant’s Overview
7.4.19.2. Financial Performance
7.4.19.3. Product Benchmarking
7.4.19.4. Recent Developments/Strategic Initiatives